Related Experiment Videos
Ventriculography with methylglucamine iocarmate (Dimer-X). Experimental and clinical study
Acta Neurochirurgica
|January 1, 1976
Summary
Meglumine iocarmate (Dimer-X) demonstrates superior safety for ventriculography compared to other contrast agents. Animal and clinical studies confirm its efficacy and minimal side effects in diagnostic imaging of the central nervous system.
Area of Science:
- Radiology
- Neuroradiology
- Medical Imaging
Background:
- Meglumine iocarmate (Dimer-X) is a water-soluble contrast medium evaluated for ventriculography.
- Previous studies established its safety for myelography.
Observation:
- Animal experiments involved injecting Dimer-X into canine ventricles, comparing it with meglumine iothalamate (Conray 60) and meglumine diatrizoate (Angiografin).
- Clinical studies assessed Dimer-X in patients with central nervous system diseases undergoing ventriculography.
Findings:
- Dimer-X exhibited fewer side effects than Conray 60 and Angiografin in animal models.
- No significant differences in ventriculogram intensity were observed between agents.
- Histological examinations revealed no ventricular abnormalities one month post-injection.
- Clinical use of Dimer-X yielded good diagnostic ventriculograms with minimal adverse events like headache or vomiting in a few cases.
Implications:
- Dimer-X presents a safer alternative contrast agent for ventriculography.
- Its favorable safety profile supports its use in diagnostic imaging of neurological conditions.
- Further research may explore its broader applications in neuroimaging procedures.